| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/30/2010 | WO2010111527A1 Pyrazolo [ 3, 4 -b] pyridines as kinase inhibitors and their medical use |
| 09/30/2010 | WO2010111432A1 Atropisomers of2-purinyl-3-tolyl-quinazolinone derivatives and methods of use |
| 09/30/2010 | WO2010111406A2 Compounds and therapeutic uses thereof |
| 09/30/2010 | WO2010111254A1 Novel anti-alpha5beta1 antibodies and uses thereof |
| 09/30/2010 | WO2010110993A2 Methods and compositions for the treatment of cancer |
| 09/30/2010 | WO2010110686A1 Pyrimidinyl and 1,3,5 triazinyl benzimidazoles and their use in cancer therapy |
| 09/30/2010 | WO2010110684A1 Nitric oxide donors |
| 09/30/2010 | WO2010110479A1 Activator for peroxisome proliferator-activated receptor |
| 09/30/2010 | WO2010110455A1 Polyion complex comprising hydrophobized polyamino acid and use of same |
| 09/30/2010 | WO2010110440A1 Novel therapeutic agent for cognitive impairment |
| 09/30/2010 | WO2010110223A1 Fucoidan having antitumor activity |
| 09/30/2010 | WO2010109961A1 Burdock fruit extract containing arctigenin at high content and process for producing same |
| 09/30/2010 | WO2010109924A1 Lh-type bispecific antibody |
| 09/30/2010 | WO2010109706A1 Therapeutic agent for cancer having reduced sensitivity to molecular targeted drug, and pharmaceutical composition for enhancing sensitivity to molecular targeted drug |
| 09/30/2010 | WO2010109450A1 Rhodamine 6g for use in treating cancerous cells |
| 09/30/2010 | WO2010109284A1 Antimicrobial cationic lipo-beta-peptides |
| 09/30/2010 | WO2010109230A1 Novel prodrugs |
| 09/30/2010 | WO2010109123A1 Anticancer derivatives, preparation thereof, and therapeutic use thereof |
| 09/30/2010 | WO2010109122A1 Nicotinamide derivatives, preparation thereof, and therapeutic use thereof as anticancer drugs |
| 09/30/2010 | WO2010109115A1 Anticancer compounds, preparation thereof, and therapeutic use thereof |
| 09/30/2010 | WO2010108931A1 Combination of an oncolytic adenovirus and a calcium channel blocker and its use for the treatment of cancer |
| 09/30/2010 | WO2010108921A1 N-aryl-2-(2-arylaminopyrimidin-4-yl)pyrrol-4-carboxamide derivatives as mps1 kinase inhibitors |
| 09/30/2010 | WO2010108824A1 L-plastin antibodies and their use |
| 09/30/2010 | WO2010108652A1 Dihydropyridin sulfonamides and dihydropyridin sulfamides as mek inhibitors |
| 09/30/2010 | WO2010108410A1 Use of catechin in preparation of retrovirus integrase inhibitor |
| 09/30/2010 | WO2010108215A1 Compounds and methods for modulating an immune response |
| 09/30/2010 | WO2010093263A8 Compositions and methods for the treatment and prevention of neoplastic disorders |
| 09/30/2010 | WO2010089510A3 Derivatives of azaspiranyl-alkylcarbamates of 5-member heterocyclic compounds, preparation thereof and therapeutic use thereof |
| 09/30/2010 | WO2010080248A3 Peptides that bind eukaryotic translation initiation factor 4e |
| 09/30/2010 | WO2010075418A3 Glyceollins suppress androgen-responsive prostate cancer |
| 09/30/2010 | WO2010068710A3 Kinase inhibitor compounds |
| 09/30/2010 | WO2010056919A3 Eflornithine prodrugs, conjugates and salts, and methods of use thereof |
| 09/30/2010 | WO2010003022A8 Isoindolone derivatives as mek kinase inhibitors and methods of use |
| 09/30/2010 | US20100249243 Novel beta-hydroxyketones and beta-alkoxyketones with estrogenic activity |
| 09/30/2010 | US20100249241 N,n-dimethyl imidodicarbonimidic diamide dicarboxylate, method for producing the same and pharmaceutical compositions comprising the same |
| 09/30/2010 | US20100249239 Bis(thio-hydrazide amide) formulation |
| 09/30/2010 | US20100249226 Tumor selective and biodegradable cyclotriphosphazene-platinum(ii) conjugate anticancer agent, and preparation method thereof |
| 09/30/2010 | US20100249218 Method to inhibit cell growth using oligonucleotides |
| 09/30/2010 | US20100249217 Modulators of pharmacological agents |
| 09/30/2010 | US20100249213 MicroRNA Signatures in Human Ovarian Cancer |
| 09/30/2010 | US20100249207 Synthesis of pyrrolidine compounds |
| 09/30/2010 | US20100249205 Metabolites of Wortmannin Analogs and Methods of Using Same |
| 09/30/2010 | US20100249203 Compounds that inhibit trpv1 and uses thereof |
| 09/30/2010 | US20100249201 3-3-Di-Substituted-Oxindoles As Inhibitors of Translation Initiation |
| 09/30/2010 | US20100249197 Carbamic acid compounds comprising an amide linkage as hdac inhibitors |
| 09/30/2010 | US20100249189 Nitric oxide donor compounds |
| 09/30/2010 | US20100249185 Method for inhibiting topoisomerase ii |
| 09/30/2010 | US20100249175 Dicationic compounds which selectively recognize G-quadruplex DNA |
| 09/30/2010 | US20100249172 9-chloro noscapine and its use in treating cancers, including drug-resistant cancers |
| 09/30/2010 | US20100249161 2- ( 2 -hydroxyphenyl) -quinazolin-4-ones useful for treating obesity and diabetes |
| 09/30/2010 | US20100249160 Cancer Treatment Method |
| 09/30/2010 | US20100249159 Rho-kinase inhibitors |
| 09/30/2010 | US20100249155 Atropisomers of 2-purinyl-3-tolyl-quinazolinone derivatives and methods of use |
| 09/30/2010 | US20100249153 Substituted indolo-piperidine compounds |
| 09/30/2010 | US20100249152 New 4-substituted derivatives of pyrazolo[3,4-d pyrimidine and pyrrolo[2,3-d]pyrimidine and uses thereof |
| 09/30/2010 | US20100249149 Inhibitors of Protein Kinases |
| 09/30/2010 | US20100249145 Inhibitors of VEGF Receptor and HGF Receptor Signaling |
| 09/30/2010 | US20100249144 Substituted piperazines as cb1 antagonists |
| 09/30/2010 | US20100249143 Method for inhibiting growth of cancer cells and cell telomere and diseases of cell proliferation by using heteroannelated anthraquinone derivative compounds |
| 09/30/2010 | US20100249142 IMIDAZOL[1,2-alpha]QUINOXALINES AND DERIVATIVES FOR THE TREATMENT OF CANCERS |
| 09/30/2010 | US20100249141 Novel inhibitors of folic acid-dependent enzymes |
| 09/30/2010 | US20100249135 Sulfonamides and their use as a medicament |
| 09/30/2010 | US20100249132 Imidazole derivatives |
| 09/30/2010 | US20100249131 Morpholino pyrimidine derivatives used in diseases linked to mtor kinase and/or pi3k |
| 09/30/2010 | US20100249130 Biaryl compositions and methods for modulating a kinase cascade |
| 09/30/2010 | US20100249129 Compounds as cannabinoid receptor ligands |
| 09/30/2010 | US20100249128 Novel 3-amido-pyrrolo[3,4-c]pyrazole-5(1h,4h,6h) carbaldehyde derivatives |
| 09/30/2010 | US20100249127 Substituted indolo-pyridinone compounds |
| 09/30/2010 | US20100249126 Pyrimidine derivatives used as pi-3-kinase inhibitors |
| 09/30/2010 | US20100249123 Novel benzamide derivatives as modulators of the follicle stimulating hormone |
| 09/30/2010 | US20100249120 Substituted pyrazolo-pyrrolo-pyridine-dione compounds |
| 09/30/2010 | US20100249119 Heterocyclic compound and use thereof |
| 09/30/2010 | US20100249118 Compounds and methods for kinase modulation, and indications therefor |
| 09/30/2010 | US20100249115 Substituted heterocyclic compounds |
| 09/30/2010 | US20100249112 Combination of chk and parp inhibitors for the treatment of cancers |
| 09/30/2010 | US20100249111 Multi-ring compounds and uses thereof |
| 09/30/2010 | US20100249110 Substituted pyrazolo-pyrimidine compounds |
| 09/30/2010 | US20100249109 Substituted tetrahydropyrazolo-pyrido-azepine compounds |
| 09/30/2010 | US20100249108 Substituted dipyrido-pyrimido-diazepine and benzo-pyrido-pyrimido compounds |
| 09/30/2010 | US20100249106 Methods of Making and Using Therapeutically Active Thiophenepyrimidinone Compounds |
| 09/30/2010 | US20100249104 Methods for using vasopressin antagonists with anthracycline chemotherapy agents to reduce cardiotoxicity and/or improve survival |
| 09/30/2010 | US20100249101 Malonamide derivatives with antithrombotic activity |
| 09/30/2010 | US20100249099 Pyrimidinyl and 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy |
| 09/30/2010 | US20100249096 Azetidines as MEK Inhibitors for the Treatment of Proliferative Diseases |
| 09/30/2010 | US20100249093 Substituted Heteroarylpiperidine Derivatives As Melanocortin-4 Receptor Modulators |
| 09/30/2010 | US20100249092 Heteroaryl compounds and uses thereof |
| 09/30/2010 | US20100249091 Amide Compounds Useful in Therapy |
| 09/30/2010 | US20100249089 Abcg2 inhibitor |
| 09/30/2010 | US20100249085 Heteroaryl substituted pyrazole derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
| 09/30/2010 | US20100249082 Modulators of hypoxia inducible factor-1 and related uses |
| 09/30/2010 | US20100249078 Tetracyclic inhibitors of fatty acid amide hydrolase |
| 09/30/2010 | US20100249068 Substituted nucleoside and nucleotide analogs |
| 09/30/2010 | US20100249067 Modulators of Mitotic Kinases |
| 09/30/2010 | US20100249065 Biomarkers for Assessing Peripheral Neuropathy Response to Cancer Treatment |
| 09/30/2010 | US20100249063 Amorphous body composed of heterocyclic compound, solid dispersion and pharmaceutical preparation each comprising the same, and process for production of the same |
| 09/30/2010 | US20100249061 Oligosaccharides, preparation method and use thereof, and pharmaceutical compositions containing same |
| 09/30/2010 | US20100249055 Clofarabine phospholipid derivatives |
| 09/30/2010 | US20100249050 Epothilone glycoside and use thereof |
| 09/30/2010 | US20100249040 Alpha-fetoprotein peptides and uses thereof |
| 09/30/2010 | US20100249039 Methods for Treating Cancer Using an Immunotoxin |